BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 16167012)

  • 1. Acute promyelocytic leukemia: current strategies for the treatment of newly diagnosed disease.
    Sirulnik LA; Stone RM
    Clin Adv Hematol Oncol; 2005 May; 3(5):391-7, 429. PubMed ID: 16167012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute promyelocytic leukemia: recent advances in diagnosis and management.
    Lo-Coco F; Ammatuna E; Montesinos P; Sanz MA
    Semin Oncol; 2008 Aug; 35(4):401-9. PubMed ID: 18692690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. All-trans-retinoic acid and arsenic trioxide as initial therapy for acute promyelocytic leukemia.
    Quezada G; Kopp L; Estey E; Wells RJ
    Pediatr Blood Cancer; 2008 Jul; 51(1):133-5. PubMed ID: 18293388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
    Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N
    Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of anthracycline-based combination chemotherapy with or without all-trans retinoic acid in acute promyelocytic leukemia.
    Raza S; Ullah K; Ahmed P; Khan B
    J Coll Physicians Surg Pak; 2008 Sep; 18(9):546-50. PubMed ID: 18803891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Managing acute promyelocytic leukemia without conventional chemotherapy: is it possible?
    Park JH; Tallman MS
    Expert Rev Hematol; 2011 Aug; 4(4):427-36. PubMed ID: 21801134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Practice points, consensus, and controversial issues in the management of patients with newly diagnosed acute promyelocytic leukemia.
    Sanz MA; Tallman MS; Lo-Coco F
    Oncologist; 2005; 10(10):806-14. PubMed ID: 16314291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What is the role of arsenic in newly diagnosed APL?
    Tallman MS
    Best Pract Res Clin Haematol; 2008 Dec; 21(4):659-66. PubMed ID: 19041605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Curative therapeutic approaches to APL.
    Tallmann MS
    Ann Hematol; 2004; 83 Suppl 1():S81-2. PubMed ID: 15124685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Leukemogenesis and therapy of acute promyelocytic leukemia: from the worse to the most favorable subtype of acute myeloid leukemia].
    KorĂ­stek Z; Mayer J
    Vnitr Lek; 2008; 54(7-8):701-27. PubMed ID: 18780571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of all-trans retinoic acid in combination with arsenic trioxide for remission induction in patients with newly diagnosed acute promyelocytic leukemia and for consolidation/maintenance in CR patients.
    Dai CW; Zhang GS; Shen JK; Zheng WL; Pei MF; Xu YX; Cao YX; Yi Y; Yang JJ; Peng HL; Zhong HY; Li RJ
    Acta Haematol; 2009; 121(1):1-8. PubMed ID: 19246888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation therapy for acute promyelocytic leukemia with all-trans retinoic acid: 10-year experience of its clinical application.
    Wang Z; Sun G; Shen Z; Chen S; Chen Z
    Chin Med J (Engl); 1999 Nov; 112(11):963-7. PubMed ID: 11721474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The expanding role of arsenic in acute promyelocytic leukemia.
    Tallman MS
    Semin Hematol; 2008 Jul; 45(3 Suppl 2):S25-9. PubMed ID: 18760708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A unique case of acute promyelocytic leukemia showing monocytic differentiation after ATRA (all-trans retinoic acid) therapy.
    Naeem M; Harrison K; Barton K; Nand S; Alkan S
    Eur J Haematol; 2006 Feb; 76(2):164-6. PubMed ID: 16405439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The double hazard of thrombophilia and bleeding in acute promyelocytic leukemia.
    Tallman MS; Abutalib SA; Altman JK
    Semin Thromb Hemost; 2007 Jun; 33(4):330-8. PubMed ID: 17525890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute promyelocytic leukemia (AML-M3)--Part 1: Pathophysiology, clinical diagnosis, and differentiation therapy.
    Randolph TR
    Clin Lab Sci; 2000; 13(2):98-105. PubMed ID: 11066455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of acute promyelocytic leukemia: strategy toward further increase of cure rate.
    Ohno R; Asou N; Ohnishi K
    Leukemia; 2003 Aug; 17(8):1454-63. PubMed ID: 12886231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of acute promyelocytic leukemia in the very elderly: case report and review of the literature.
    Sham RL; Tallman MS
    Leuk Res; 2004 Dec; 28(12):1347-50. PubMed ID: 15475077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on the diagnosis of and therapy for acute promyelocytic leukemia and chronic myelogenous leukemia.
    Wujcik D
    Oncol Nurs Forum; 1996 Apr; 23(3):478-87. PubMed ID: 8801508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Open issues on bleeding and thrombosis in acute promyelocytic leukemia.
    Sanz MA; Montesinos P
    Thromb Res; 2010 Apr; 125 Suppl 2():S51-4. PubMed ID: 20434005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.